Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|5|675-689

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.5, 2009-01, pp. : 675-689

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting IAPs as An Approach to Anti-Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 3, 2011-02 ,pp. : 291-316

Bentham Science Publishers

Access to resources Recommend Favorite

Novel star HPMA-based polymer conjugates for passive targeting to solid tumors

By Etrych T.   Strohalm J.   Chytil P.   ŘŘíhová B.   Ulbrich K.  

Journal of Drug Targeting, Vol. 19, Iss. 10, 2011-12 ,pp. : 874-889

Informa Healthcare

Access to resources Recommend Favorite

Targeting Stim and Orai Proteins as an Alternative Approach in Anticancer Therapy

By  

Current Medicinal Chemistry, Vol. 23, Iss. 30, 2016-10 ,pp. : 3450-3480

Bentham Science Publishers

Access to resources Recommend Favorite